High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort study.

Aze Suzanne WilsonBethany ChoiMichael SeyTerry PonichMelanie BeatonRichard B Kim

Published in: BMC gastroenterology (2021)

Maintenance-phase infliximab trough concentrations greater than 8 μg/ml, which is higher than the currently recommended target concentration, are highly associated with histologic remission and sustained histologic remission.

Keyphrases

ulcerative colitis
disease activity
systemic lupus erythematosus
rheumatoid arthritis